# Patients' Assessment of Satisfaction for Stroke Prevention in Atrial Fibrillation

> **NCT03187197** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 1315 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Pradaxa®

## Key facts

- **NCT ID:** NCT03187197
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-20
- **Primary completion:** 2018-06-30
- **Final completion:** 2019-01-11
- **Target enrollment:** 1315 (ACTUAL)
- **Last updated:** 2020-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03187197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03187197, "Patients' Assessment of Satisfaction for Stroke Prevention in Atrial Fibrillation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03187197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*